Write a letter to the director of ICMR about the current situation of our country which is highly effected by the rise of covid 19 cases. so we seeking a relief it ICMR put able to produce vaccine
Answers
Explanation:
July 2 turned out to be an unexpectedly tumultuous day for the Indian medical community. Director general of the Indian Council of Medical Research (ICMR) Balram Bhargava sent a letter to various institutions around the country asking them to begin human clinical trials for a COVID-19 vaccine named COVAXIN, to be manufactured by Hyderabad-based drugmaker Bharat Biotech (BB).
BB had announced on June 29 via a press release that it had received permission from the Drugs Controller General of India (DCGI) to begin these trials, as well as touted a claim that COVAXIN was India’s first indigenous COVID-19 vaccine. In his July 2 letter, Dr Bhargava urged the institutions – specifically, 12 hospitals and research centres around the country – to begin enrolling participants for the clinical trial no later than July 7, and to have the vaccine ready for “public health use”, which presumably means use by doctors, by August 15.
This was by all standards less a rapid vaccine development process and more an improper one. Many observers quickly raised multiple questions about whether such a trial could even be considered legitimate.
POLITICS ECONOMY EXTERNAL AFFAIRS SECURITY CULTURE OPINION VIDEO ANALYSIS MEDIA GOVERNMENT WORLD EDITOR'S PICK TOP STORIES LIVE WIRE SCIENCE
Health
ICMR's Rush to Produce 'Indian Vaccine' for COVID-19 Suggests Politics is Driving Science
The August 15 timeline mentioned in Dr Balram Bhargava's letter is not just unrealistic, it suggests whatever approval follows cannot satisfy the usual requirements of efficacy and safety that the world expects from a vaccine.